CAYLIBSI
Live / Registered — Registered (as of 20 Feb 2024)
What this means for you
Registered since 20 Feb 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Feb 2030: the §71 affidavit of use).
Record
- Serial number
- 79365656
- Registration number
- 7307521
- Mark type
- Word mark
- Filed
- 03 Feb 2023
- Published for opposition
- 05 Dec 2023
- Registered
- 20 Feb 2024
- Next maintenance filing
- §71 affidavit of use, due by 20 Feb 2030 (grace period to 20 Aug 2030)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment and prevention of disorders and complications associated with kidney disease and end-stage kidney disease; pharmaceutical preparations for the treatment and prevention of dialysis conditions; pharmaceutical preparations for the treatment and prevention of calcification disorders
Owner
Prosecution history
- 06 May 2024 — NOTIFICATION PROCESSED BY IB
- 21 Mar 2024 — GENERIC MADRID TRANSACTION SENT TO IB
- 21 Mar 2024 — GENERIC MADRID TRANSACTION CREATED
- 21 Mar 2024 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 20 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 05 Dec 2023 — PUBLISHED FOR OPPOSITION
- 04 Dec 2023 — NOTIFICATION PROCESSED BY IB
- 15 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 15 Nov 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 15 Nov 2023 — NOTICE OF PUBLICATION
- 02 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Nov 2023 — ASSIGNED TO EXAMINER
- 04 Apr 2023 — APPLICATION FILING RECEIPT MAILED
- 31 Mar 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Mar 2023 — LIMITATION FROM ORIGINAL APPLICATION ENTERED